Kite's CAR T therapy Tecartus authorised in EU for MCL
CHMP backed the CAR T cell therapy for the treatment of mantle cell lymphoma back in October
17th December 2020
Latest news
Valneva starts UK-based early-stage COVID-19 vaccine trial
French biotech will test vaccine candidate on 150 volunteers across four sites
17th December 2020
New research reveals impact of childhood type 1 diabetes on mental health
Surveys uncovers findings pre- and post-pandemic
16th December 2020
NICE recommends Novartis’ wet AMD drug Beovu
Final appraisal determination recommends anti-VEGF treatment for NHS use
16th December 2020
Novo Holdings establishes rare bleeding disorder firm Hemab
New company will focus on developing bispecific antibodies for rare bleeding disorders
16th December 2020
AZ acquires rare disease specialist Alexion
British drugmaker will acquire Alexion for approximately $39bn
16th December 2020
RDIF confirms Sputnik V COVID vaccine’s efficacy
The Russian Direct Investment Fund has released a new analysis of data obtained 21 days after administering the first dose of the vaccine, showing efficacy of 91.4%
15th December 2020
Pandemic has made little positive impact on public's view of pharma
A new report launched by Takeda has found that just 17% of UK adults surveyed felt their perception of pharma had improved based on the industry's response to COVID-19
15th December 2020
Green light for UK trial of nasal coronavirus vaccine
The trial is expected to begin next month, with first data anticipated in the second quarter of 2020
15th December 2020
New variant of coronavirus identified in the UK
PHE says it is investigating more than a thousand cases of the new strain
15th December 2020
NICE u-turn on Novartis' migraine drug Aimovig
New analyses submitted by Novartis has helped to secure a NICE recommendation for NHS funding
14th December 2020
Novartis’ cholesterol med Leqvio wins EU approval
Drug approved to help reduce cholesterol levels
14th December 2020
EU for AZ' COPD maintenance therapy
The triple combination therapy Trixeo Aerosphere cut the rate of moderate or severe exacerbations compared with dual-combination therapies in clinical trials
14th December 2020
Bumper December meeting sees CHMP recommend 15 new medicines
Ehertu, Inrebic and Retsevmo among positive recommendations
14th December 2020
Albireo submits rare liver disease med odevixibat to FDA and EMA
If approved, drug will become first treatment for PFIC patients in the US and EU
11th December 2020
